Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155-Reference-Cited by-同舟云学术

Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

Published:2011-09-25 Issue:10 Volume:17 Page:1275-1282
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Chang Suhwan, ,Wang Rui-Hong,Akagi Keiko,Kim Kyung-Ae,Martin Betty K,Cavallone Luca,Haines Diana C,Basik Mark,Mai Phuong,Poggi Elizabeth,Isaacs Claudine,Looi Lai M,Mun Kein S,Greene Mark H,Byers Stephen W,Teo Soo H,Deng Chu-Xia,Sharan Shyam K

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2459.pdf

Reference46 articles.

1. O'Donovan, P.J. & Livingston, D.M. BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis 31, 961–967 (2010).

2. Venkitaraman, A.R. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu. Rev. Pathol. 4, 461–487 (2009).

3. Deng, C.X. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 34, 1416–1426 (2006).

4. Xia, Y., Pao, G.M., Chen, H.W., Verma, I.M. & Hunter, T. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J. Biol. Chem. 278, 5255–5263 (2003).

5. Baer, R. & Ludwig, T. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr. Opin. Genet. Dev. 12, 86–91 (2002).

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cross-sectional study comparing the expression of DNA repair molecules in subjects with and without atherosclerotic plaques;Molecular Biology Reports;2024-09-04

2. The Predictive Value of Blood-Derived Exosomal miRNAs as Biomarkers in Breast Cancer: A Systematic Review;Clinical Breast Cancer;2024-07

3. Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC);International Journal of Molecular Sciences;2024-02-23

4. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription;Theranostics;2024

5. The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic BRCA1 mutations;Frontiers in Oncology;2023-12-11